Osteonecrosis and Highly Active Antiretroviral Therapy During HIV Infection: Report of a Series and Literature Review
- 1 July 2001
- journal article
- case report
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 15 (7) , 385-389
- https://doi.org/10.1089/108729101750301933
Abstract
Osteonecrosis has shown an increased incidence in HIV-infected patients during the last few years, and has been looked as a side effect of highly active antiretroviral therapy, possibly related to hyperlipidemia. Five cases of osteonecrosis were observed among over 1300 patients with HIV disease. According to our experience, novel antiretroviral regimens do not represent a constant risk factor for avascular necrosis of bone during HIV infection.Keywords
This publication has 11 references indexed in Scilit:
- Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapyAIDS, 2001
- Osteonecrosis of the hip, lipodystrophy and antiretroviral treatmentAIDS, 2000
- Bone mineral loss in HIV-positive patients receiving antiretroviral therapyAIDS, 2000
- Avascular Necrosis of the Femoral Head: A Side Effect of Highly Active Antiretroviral Therapy (HAART) in HIV Patients?Infection, 2000
- Aseptic Necrosis in HIV Seropositive Patients: A Possible Etiologic Role for Megestrol AcetateAIDS Patient Care and STDs, 2000
- Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapyAIDS, 2000
- Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* studyAIDS, 2000
- Avascular necrosis in HIV infectionAIDS, 1999
- Avascular necrosis of bone in human immunodeficiency virus infected patientsClinical Imaging, 1999
- Osteonecrosis of the femoral head in patients receiving HIV protease inhibitorsAIDS, 1999